Robin Feldman | |
|---|---|
 | |
| Nationality | American |
| Occupation(s) | Law Professor, Author |
| Known for | Intellectual property, healthcare law |
| Title | Arthur J. Goldberg Distinguished Professor of Law |
| Academic background | |
| Education | (JD) |
| Academic work | |
| Institutions | UC Hastings College of Law |
| Main interests | intellectual property law, healthcare law with a focus on the pharmaceutical industry and drug prices, artificial intelligence |
| Website | https://www.uchastings.edu/people/robin-feldman/ |
Robin Feldman is a law professor, researcher, and author best known for her contributions to intellectual property and health care law. Feldman is the Arthur J. Goldberg Distinguished Professor of Law at the UC Law San Francisco (formerly University of California, Hastings College of Law.)[1][2] Feldman is a widely cited expert on intellectual property and health care law, particularly as it relates to the pharmaceutical industry, drug policy, and drug pricing.[3][4][5][6][7][8][9][10][11]
- ^ "Professor Robin Feldman Homepage".
- ^ "UC Hastings Faculty Bibliographies".
- ^ "Drugmakers Now Masters at Rolling out Their Own Generics to Stifle Competition". Kaiser Health News. August 5, 2019.
- ^ "Capsule: Get Ready for a Gilead, HHS Truvada Patent Shootout". Bloomberg Law.
- ^ "Doctors Discover Copyright Law: Cognitive Screen Test Killed Over Infringement Claims". TechDirt. December 30, 2011.
- ^ "Abuse Deterrent Opioids and the Law of Unintended Consequences". Cato Institute.
- ^ "Protect at All Costs: How the Maker of the World's Bestselling Drug Keeps Prices Sky-High". Fortune.
- ^ "Who Cheated Whom? Apple v. Samsung Patent Showdown Explained". Wired.
- ^ "Human Longevity accuses its founder Craig Venter of stealing trade secrets". Med City News. July 29, 2018.
- ^ "Letter to FDA on Generic Drug Access" (PDF). Consumer Action.org.
- ^ "Patent Assertion Entity Activity: An FTC Study" (PDF). Federal Trade Commission.